RiboTargets Ltd. 's investors got the biggest haircut, but British Biotech PLC , the scandal-tarnished one-time flagship of the UK's biotechnology industry, has emerged from a proposed £26 million ($40.7 million) merger with the brand-new look [See Deal].
Now British Biotech—which is also in the process of changing its name—will boast a new research platform, a new CEO...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?